Daniel Regan

2015

In 2015, Daniel Regan earned a total compensation of $392.5K as Former Chief Commercial Officer at Intercept Pharmaceuticals, a 68% decrease compared to previous year.

Compensation breakdown

Salary$350,538
Other$41,962
Total$392,500

Regan received $350.5K in salary, accounting for 89% of the total pay in 2015.

Regan also received $42K in other compensation.

Rankings

In 2015, Daniel Regan's compensation ranked 11,613th out of 13,638 executives tracked by ExecPay. In other words, Regan earned more than 14.8% of executives.

ClassificationRankingPercentile
All
11,613
out of 13,638
15th
Division
Manufacturing
4,460
out of 5,190
14th
Major group
Chemicals And Allied Products
1,645
out of 1,854
11th
Industry group
Drugs
1,359
out of 1,528
11th
Industry
Pharmaceutical Preparations
1,054
out of 1,182
11th
Source: SEC filing on June 20, 2016.

Regan's colleagues

We found five more compensation records of executives who worked with Daniel Regan at Intercept Pharmaceuticals in 2015.

2015

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2015

Lisa Bright

Intercept Pharmaceuticals

Chief Commercial and Corporate Affairs Officer

2015

David Shapiro

Intercept Pharmaceuticals

Chief Medical Officer

2015

Barbara Duncan

Intercept Pharmaceuticals

Chief Financial Officer

2015

Rachel McMinn

Intercept Pharmaceuticals

Chief Strategy and Business Officer

You may also like